| DDAVP, dDAVP | 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin |
|---|---|
| AK | above knee; acetate kinase; adenosine kinase; adenylate kinase; artificial kidney |
| CK | calf kidney; casein kinase; chicken kidney; cholecystokinin; choline kinase; contralateral knee; cre... |
| TK | thymidine kinase; transketolase; triose-kinase; tyrosine kinase |
| CDK | cell division kinase; climatic droplet keratopathy; cyclin-dependent kinase |
| L-NAME | L-arginine and NG-nitro-L-arginine methyl ester |
|---|---|
| HDAC | 1/histone deacetylase |
| AHA | Anti-histone antibodies |
| H1 | Histone 1 |
| HAT | Histone acetyl transferase |
creatine kinase
| calcium-calmodulin-activated histone 3 arginine kinase | <enzyme> From nuclear extracts of dividing and quiescent rat heart endothelial cells; represents a new class of ca-cam-dependent kinases which phosphorylate arg Registry number: EC 2.7.10.- Synonym: ca(2+)-calmodulin-activated histone 3 arg kinase, ca-cam h3 kinase (26 Jun 1999) |
|---|
| histone h2b kinase | <enzyme> 96 kD serine kinase from xenopus that phosphorylates histone h2b; a component or target of the raf-mek-erk pathway Registry number: EC 2.7.1.- Synonym: p96(h2bk) (26 Jun 1999) |
|---|---|
| arginine kinase | <enzyme> An enzyme that catalyses the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. Chemical name: ATP:L-arginine N-phosphotransferase Registry number: EC 2.7.3.3 (12 Dec 1998) |
| MAP kinase kinase kinase | <enzyme> From pc12 cells; reactivates map kinase kinase inactivated by protein phosphatase 2a by phosphorylation of serine residues; tak1 (tgf-beta-activated kinase 1) is a member of the mapkkk family; genbank ab006787 (mouse) Registry number: EC 2.7.10.- Synonym: mapkkk, tak1 mapkkk, ask1 (kinase), apoptosis signal-regulating kinase 1 (26 Jun 1999) |
| ADP ribose-histone hydrolase | <enzyme> Splits bond between ADP ribose and histone Registry number: EC 4.2.99.- Synonym: ADP-ribosyl histone splitting enzyme, ADP-ribosyl protein lyase (26 Jun 1999) |
| chromosomal proteins, non-histone | Nucleoproteins which in contrast to histones are acid insoluble. They are involved in chromosomal functions; e.g. They bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. (12 Dec 1998) |
| histone | <molecular biology> Protein found in the nuclei of all eukaryotic cells where they are complexed to DNA in chromatin and chromosomes. They are of relatively low molecular weight and are basic, having a very high arginine/lysine content. They are highly conserved and can be grouped into five major classes. Two copies of H2A, H2B, H3 and H4 bind to about 200 base pairs of DNA to form the repeating structure of chromatin, the nucleosome, with H1 binding to the linker sequence. They may act as non-specific repressors of gene transcription. (18 Nov 1997) |
| histone bases | The alpha-amino acids arginine, histidine, and lysine, which are basic by virtue of the presence in the side chains of a guanidine, imidazole, and amine group, respectively; the term "hexone" is a misnomer since histidine does not have six carbons. (05 Mar 2000) |
| histone deacetylase | <enzyme> Hydrolyzes n-acetyl groups on histones. Registry number: EC 3.5.1.- (12 Dec 1998) |
| histone gene | A histone gene is any gene which codes for histone proteins. (Histones help compact DNA so that it will fit into an eukaryotic cells nucleus). (09 Oct 1997) |
| histone-lysine n-methyltransferase | <enzyme> An enzyme that catalyses the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. Chemical name: S-Adenosyl-L-methionine:histone-L-lysine N(6)-methyltransferase Registry number: EC 2.1.1.43 (12 Dec 1998) |
| arginine | <amino acid> An essential amino acid, a major component of proteins and contains the guanido group that has a pKa of greater than 12, so that it carries a permanent positive charge at physiological pH. It becomes an essential amino acid when the body is under stress or is in an injured state. Depressed growth results from lack of dietary arginine. Arginine deficiency syndrome is observed in human babies born with a phosphate synthetase deficiency. Normal growth and development in these infants are achieved by adding arginine to their diet. Arginine deficiency leads to carbamyl phosphate overproduction in the mitochondria due to inadequate ornithine supply. Arginine-deficient diets in males causes decreased sperm counts. Free and bound arginine are found in abundance in human male sperm and arginine has been found to stimulate sperm motility. There are two sources of arginine, arginine in the food chain and free-form arginine from supplements. Food-source arginine is found in abundance in turkey, chicken and other meats. Nonfood-source arginine is called L-arginine and is created through a fermentation process which separates arginine from all other proteins. In the presence of food and other amino acids, L-arginine will act like food-source arginine but when L-arginine is separated from its nutrient boundaries by the removal of all other amino acids, then L-arginine undertakes a different role, becoming capable of crossing the blood-brain barrier and stimulating growth hormone release secreted by the anterior pituitary. Growth hormone serum levels peak during adolescence and begin to drop after age 23. Aging reduces natural growth hormone production, which results in added body fat, reduced muscle tissue, slowed healing, lack of elasticity in the skin and reduced immune function. Human pituitary growth hormone secretion is evidenced in human males, females and children following intravenous administration of 30 grams of arginine (in 30 minutes) in adults and 0.5 grams/kilogram of bodyweight in children. Female response is somewhat higher than male response. Oral administration of L-arginine also results in the release of Human Growth Hormone. Tumour suppression is evidenced in the presence of L-arginine. In the Barbul study, tumours recurred in 100% of the control animals. But in the arginine-supplemented group, only about 60% of the tumours recurred and the animals with tumours survived longer. Supplementation of arginine in the diet inhibits development and increase in size of cancerous tumours, both chemically induced and naturally occurring. Insulin can block growth hormone release, so high serum insulin levels are counterproductive to GH release. Insulin itself is capable of stimulating muscle growth, but it also strongly stimulates fat storage. Muscle growth stimulation from insulin is minuscule compared to muscle growth stimulated by growth hormone. (13 Nov 1997) |
| arginine 2-monooxygenase | <enzyme> Catalyses oxidative decarboxylation or arginine to form gamma-guanidinobutyramide (4-guanidinobutanamide) Registry number: EC 1.13.12.1 Synonym: arginine decarboxyoxidase (26 Jun 1999) |
| arginine amidase | <enzyme> A ureahydrolase that catalyses the hydrolysis of arginine and canavanine to yield l-ornithine and urea. Chemical name: L-Arginine amidinohydrolase Registry number: EC 3.5.3.1 (12 Dec 1998) |
| arginine deiminase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine dihydrolase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|